Schrödinger Inc. (Nasdaq: SDGR)

https://www.schrodinger.com

LinkedIn: https://www.linkedin.com/company/schr-dinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs. Founded in 1990, Schrödinger has over 400 employees and is engaged with customers and collaborators in more than 70 countries. *

	Start	1990-01-01 established
	Group	Schrödinger (Group)
	Industry	software
	Industry 2	AI-based drug discovery / AI-based drug development
	Person	Farid, Ramy (Schrödinger 202011 CEO)

	Region	New York, NY
	Country	United States (USA)
	Street	120 West 45th Street 17th Floor
	City	10036-4041 New York, NY
	Tel	+1-212-295-5800
		Address record changed: 2024-01-05

Basic data	Employees	D: 101 to 500 (2020-11-23)

		* Document for »About Section«: Schrödinger, Inc.. (11/23/20). "Press Release: Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb". New York, NY.

		Record changed: 2024-06-20